Developing a subcommittee to evaluate the use of specialty medications among inpatients helped pharmacists at Bryan Medical Center, in Lincoln, Neb., save nearly $650,000 in the first year alone. This financial boon came from evaluating just four medications, according to a presentation at the ASHP 2020 Midyear Clinical Meeting and Exposition.
The work began with an evaluation of andexanet alfa (Andexxa, Portola) in the main Pharmacy and Therapeutics